{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:33Z","timestamp":1760028573151,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Council","award":["MR\/N003322\/1"],"award-info":[{"award-number":["MR\/N003322\/1"]}]},{"name":"CPRD Independent Scientific Advisory Committee","award":["ISAC 13_1377R"],"award-info":[{"award-number":["ISAC 13_1377R"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To estimate the incidence of cardiovascular (CV) events in idiopathic inflammatory myopathy (IIM) compared to patients with rheumatoid arthritis (RA) and the general population. To explore the contribution of traditional CV risk factors to any difference observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective matched population-based cohort study was conducted using UK Clinical Practice Research Datalink (CPRD) from 1987 to 2013. The incidence of CV events was calculated for each cohort over time and compared using Cox proportional hazards models. Multivariable analyses were used to adjust for traditional CV risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 603 patients with IIM 4047 RA and 4061 healthy controls were included. The rate of CV events in IIM was significantly greater than healthy controls [hazard ratio (HR) 1.47 (95% confidence interval (CI) 1.18\u20131.83)] and remained significant after adjustment for CV risk factors [HR 1.38 (95% CI 1.11\u20131.72)]. Risk was similar between IIM and RA [HR 1.01 (95% CI 0.78\u20131.31)]. The rate of myocardial infarction [HR 1.61 (95% CI 1.27\u20132.04)] but not stroke [HR 0.92 (95% CI 0.59\u20131.44)] was significantly greater in IIM compared to healthy controls. After the first 5\u00a0years, the rate of CV events for RA remained significantly greater compared to the control group, but appeared to return to that of the healthy controls in the IIM group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>IIM is associated with an increased risk of CV events in the first 5\u00a0years after diagnosis similar to that of RA. Beyond 5\u00a0years, the risk appears to return to that of the general population in IIM but not RA.<jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold><jats:italic>\u2022 The excess risk of cardiovascular events in IIM is similar to that found in RA.<\/jats:italic><jats:italic>\u2022 The excess risk of cardiovascular events is greatest in the first 5\u00a0years after diagnosis.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-020-05237-7","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:02:57Z","timestamp":1592823777000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5\u00a0years after diagnosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-4535","authenticated-orcid":false,"given":"Cristina","family":"P\u00e1rraga Prieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fowzia","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"4","key":"5237_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","volume":"8","author":"BJ Skaggs","year":"2012","unstructured":"Skaggs BJ, Hahn BH, McMahon M (2012) Accelerated atherosclerosis in patients with SLE--mechanisms and management. Nat Rev Rheumatol 8(4):214\u2013223","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"5237_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","volume":"11","author":"S Skeoch","year":"2015","unstructured":"Skeoch S, Bruce IN (2015) Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 11(7):390\u2013400","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"5237_CR3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA. 296(14):1735\u20131741","journal-title":"JAMA."},{"issue":"10","key":"5237_CR4","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, C\u00f4te R, Grover SA, Fortin PR, Clarke AE, Sen\u00e9cal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331\u20132337","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5237_CR5","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rinc\u00f3n","year":"2001","unstructured":"del Rinc\u00f3n ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737\u20132745","journal-title":"Arthritis Rheum"},{"issue":"11","key":"5237_CR6","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2013-203433","volume":"73","author":"L Eder","year":"2014","unstructured":"Eder L, Chandran V, Gladman DD (2014) The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73(11):1990\u20131996","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5237_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2003.09.037","volume":"93","author":"LM Fischer","year":"2004","unstructured":"Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR (2004) Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 93(2):198\u2013200","journal-title":"Am J Cardiol"},{"key":"5237_CR8","doi-asserted-by":"crossref","unstructured":"Studynkova JT, Mann H, Jarosova K et al (2014) A prospective, randomized, open-label, assessor-blind, multicenter study of efficacy and safety of combined treatment of methotrexate + glucocorticoids versus glucocorticoids alone in patients with polymyositis and dermatomyositis (prometheus trial). Ann Rheum Dis 73(Suppl 2)","DOI":"10.1136\/annrheumdis-2014-eular.3886"},{"issue":"3","key":"5237_CR9","doi-asserted-by":"publisher","first-page":"R545","DOI":"10.1186\/ar1715","volume":"7","author":"M De Bandt","year":"2005","unstructured":"De Bandt M, Sibilia J, Le Lo\u00ebt X et al (2005) Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther. 7(3):R545\u2013R551","journal-title":"Arthritis Res Ther."},{"issue":"11","key":"5237_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/ard.2011.150326","volume":"70","author":"BW Higgs","year":"2011","unstructured":"Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y (2011) Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 70(11):2029\u20132036","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5237_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","volume":"37","author":"CM Magro","year":"2010","unstructured":"Magro CM, Segal JP, Crowson AN, Chadwick P (2010) The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol 37(6):659\u2013671","journal-title":"J Cutan Pathol"},{"issue":"5","key":"5237_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037000","volume":"7","author":"EC Somers","year":"2012","unstructured":"Somers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, Kazerooni EA, McCune WJ, Kaplan MJ (2012) Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. PLoS One 7(5):e37000","journal-title":"PLoS One"},{"issue":"11","key":"5237_CR13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10067-014-2561-y","volume":"33","author":"M Vincze","year":"2014","unstructured":"Vincze M, D\u00e9r H, Kerekes G et al (2014) Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol 33(11):1635\u20131641","journal-title":"Clin Rheumatol"},{"issue":"3","key":"5237_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L (2015) Data resource profile: clinical practice research Datalink (CPRD). Int J Epidemiol 44(3):827\u2013836","journal-title":"Int J Epidemiol"},{"key":"5237_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ (2010) Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol 69:4\u201314","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"5237_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/rheumatology\/key013","volume":"57","author":"A Abhishek","year":"2018","unstructured":"Abhishek A, Nakafero G, Kuo CF, Mallen C, Zhang W, Grainge MJ, Doherty M (2018) Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from clinical practice research Datalink. Rheumatology (Oxford) 57(6):977\u2013981","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5237_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/bjd.12245","volume":"168","author":"YT Lai","year":"2013","unstructured":"Lai YT, Dai YS, Yen MF, Chen LS, Chen HH, Cooper RG, Pan SL (2013) Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow-up study. Br J Dermatol 168(5):1054\u20131059","journal-title":"Br J Dermatol"},{"issue":"2","key":"5237_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/acr.21820","volume":"65","author":"KH Yu","year":"2013","unstructured":"Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ (2013) Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken) 65(2):244\u2013250","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"5237_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7(3):e33442","journal-title":"PLoS One"},{"issue":"9","key":"5237_CR20","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3899\/jrheum.090061","volume":"36","author":"A Tisseverasinghe","year":"2009","unstructured":"Tisseverasinghe A, Bernatsky S, Pineau CA (2009) Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 36(9):1943\u20131946","journal-title":"J Rheumatol"},{"issue":"3","key":"5237_CR21","first-page":"461","volume":"55","author":"SK Rai","year":"2016","unstructured":"Rai SK, Choi HK, Sayre EC, Avi\u00f1a-Zubieta JA (2016) Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford) 55(3):461\u2013469","journal-title":"Rheumatology (Oxford)"},{"key":"5237_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000255968","volume":"29","author":"J Finsterer","year":"2010","unstructured":"Finsterer J, St\u00f6llberger C (2010) Stroke in myopathies. Cerebrovasc Dis 29:6\u201313","journal-title":"Cerebrovasc Dis"},{"key":"5237_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874205X01206010026","volume":"6","author":"J Finsterer","year":"2012","unstructured":"Finsterer J (2012) Stroke and stroke-like episodes in muscle disease. Open Neurol J 6:26\u201336","journal-title":"Open Neurol J"},{"key":"5237_CR24","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR (2018) Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 361:k1036. https:\/\/doi.org\/10.1136\/bmj.k1036","journal-title":"BMJ"},{"issue":"2","key":"5237_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000291","volume":"2","author":"T Schwartz","year":"2016","unstructured":"Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad Iand Sanner H (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open 2(2):e000291","journal-title":"RMD Open"},{"issue":"8","key":"5237_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/aje\/kws130","volume":"176","author":"LS Magder","year":"2012","unstructured":"Magder LS, Petri M (2012) Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 176(8):708\u2013719","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5237_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes I, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5237_CR28","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, M\u00f6ller B, Ljung L, Magnusson S, Smedby T, S\u00f6dergren A, \u00d6hman ML, Rantap\u00e4\u00e4-Dahlqvist S, W\u00e5llberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13(4):R131","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5237_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41(1):22\u201326","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5237_CR30","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","volume":"53","author":"H Sanner","year":"2014","unstructured":"Sanner H, Sjaastad I, Flat\u00f8 B (2014) Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric rheumatology international trials organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatology (Oxford) 53(9):1578\u20131585","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5237_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2014-206812","volume":"74","author":"M Hughes","year":"2015","unstructured":"Hughes M, Lilleker JB, Herrick AL, Chinoy H (2015) Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity. Ann Rheum Dis 74(5):795\u2013798","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5237_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/rheumatology\/key031","volume":"57","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB, Diederichsen ACP, Jacobsen S, Guy M, Roberts ME, Sergeant JC, Cooper RG, Diederichsen LP, Chinoy H (2018) Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies. Rheumatology (Oxford) 57(6):1041\u20131046","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5237_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00415-014-7623-1","volume":"262","author":"A Rosenbohm","year":"2015","unstructured":"Rosenbohm A, Buckert D, Gerischer N, Walcher T, Kassubek J, Rottbauer W, Ludolph AC, Bernhardt P (2015) Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J Neurol 262(4):949\u2013956","journal-title":"J Neurol"},{"issue":"2","key":"5237_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","volume":"93","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Abenhaim L, Begaud B, Zhang B, Cooper C (2000) Use of oral corticosteroids in the United Kingdom. QJM 93(2):105\u2013111","journal-title":"QJM"},{"issue":"5 Suppl 51","key":"5237_CR35","first-page":"S109","volume":"26","author":"IE Lundberg","year":"2008","unstructured":"Lundberg IE, Forbess CJ (2008) Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 26(5 Suppl 51):S109\u2013S114","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5237_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijcard.2010.08.013","volume":"148","author":"R Gupta","year":"2011","unstructured":"Gupta R, Wayangankar SA, Targoff IN, Hennebry TA (2011) Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 148(3):261\u2013270","journal-title":"Int J Cardiol"},{"issue":"11","key":"5237_CR37","first-page":"686","volume":"35","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang GC, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35(11):686\u2013691","journal-title":"Clin Cardiol"},{"issue":"12","key":"5237_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2459\/JCM.0b013e32833cdca8","volume":"11","author":"C Bazzani","year":"2010","unstructured":"Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F (2010) Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) 11(12):906\u2013911","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"5237_CR39","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar4135","volume":"15","author":"E Linos","year":"2013","unstructured":"Linos E, Fiorentino D, Lingala B, Krishnan E, Chung L (2013) Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide inpatient sample survey. Arthritis Res Ther 15(1):R7","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05237-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05237-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05237-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:10:51Z","timestamp":1624320651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05237-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5237"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05237-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Approval for the study was granted by the CPRD Independent Scientific Advisory Committee (ISAC 13_1377R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}